We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$640M
AUM Growth
+$42M
Cap. Flow
+$22.9M
Cap. Flow %
3.57%
Top 10 Hldgs %
39.6%
Holding
108
New
27
Increased
17
Reduced
24
Closed
21

Top Buys

Rank Stock Value
1
PRAX icon
Praxis Precision Medicines
PRAX
+$8.95M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$7.93M
3
SHLT
SHL Telemedicine Ltd American Depositary Shares
SHLT
+$7.92M
4
NVMI
Nova
NVMI
+$7.16M
5
TSEM icon
Tower Semiconductor
TSEM
+$6.92M

Top Sells

Rank Stock Value
1
NTR icon
Nutrien
NTR
+$10.7M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$8.87M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$8.02M
4
LLY icon
Eli Lilly
LLY
+$6.71M
5
MSFT icon
Microsoft
MSFT
+$6.37M

Sector Composition

Rank Sector Weight
1 Healthcare 57.28%
2 Technology 9.65%
3 Consumer Discretionary 2.53%
4 Utilities 0.59%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLI icon
101
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
– –
-57,700
Closed -$5.84M
RETA
102
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-7,689
Closed -$699K
KDNY
103
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-92,200
Closed -$2.13M
OTMO
104
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
– –
-26,124
Closed -$186K
BLU
105
DELISTED
BELLUS Health Inc.
BLU
– –
-799,860
Closed -$5.76M
ONCR
106
DELISTED
Oncorus, Inc.
ONCR
– –
-540,258
Closed -$186K
1 2 3 4
5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q2 2023 Portfolio in Review

As of Q2 2023, Sphera Funds Management held 108 positions worth $640M, up 7% from $598M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sphera Funds Management deployed $22.9M of net new capital in Q2 2023, opening 27 new positions and adding to 17 existing holdings. Its largest new stake was Praxis Precision Medicines: 584,289 shares worth $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $8.02M trimmed.

  • Sphera Funds Management's largest Q2 2023 buy was Praxis Precision Medicines: 584,289 shares worth $10.1M.
  • Sphera Funds Management added most to Amazon in Q2 2023, an estimated $4.41M increase.
  • Sphera Funds Management's biggest Q2 2023 reduction was Teva Pharmaceuticals, cutting an estimated $8.02M.
  • Sphera Funds Management fully exited Nutrien in Q2 2023, selling an estimated $10.7M.
  • Sphera Funds Management's ten largest holdings make up 40% of its $640M portfolio in Q2 2023.
  • Sphera Funds Management opened 27 new positions and closed 21 in Q2 2023.
  • Sphera Funds Management's portfolio value rose 7% quarter-over-quarter to $640M.

Based on Sphera Funds Management's 13F filing for Q2 2023, filed 14 Aug 2023.